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This study investigated possible analgesic and anti-inﬂammatory mechanisms of the methanol extract of Ficus pumila (FPMeOH).
Analgesic eﬀects were evaluated in two models including acetic acid-induced writhing response and formalin-induced paw
licking. The results showed FPMeOH decreased writhing response in the acetic acid assay and licking time in the formalin test.
The anti-inﬂammatory eﬀect was evaluated by λ-carrageenan-induced mouse paw edema and histopathological analyses. FPMeOH
signiﬁcantly decreased the volume of paw edema induced by λ-carrageenan. Histopathologically, FPMeOH abated the level of tissue
destructionandswellingoftheedemapaws.Thisstudyindicatedanti-inﬂammatorymechanismofFPMeOH maybeduetodeclined
levels of NO and MDA in the edema paw through increasing the activities of SOD, GPx, and GRd in the liver. Additionally, FPMeOH
also decreased the level of inﬂammatory mediators such as IL-1β,T N F - α, and COX-2. HPLC ﬁngerprint was established and the
contents of three active ingredients, rutin, luteolin, and apigenin, were quantitatively determined. This study provided evidence
for the classical treatment of Ficus pumila in inﬂammatory diseases.
1.Introduction
Inﬂammatory reaction, typically characterized by redness,
swelling, heat, and pain, is one of the most important host
defense mechanisms against invading pathogens. However,
persistent or overinﬂammation leads to tissue damage and
possibly failure of organs. Proinﬂammatory cytokines (e.g.,
TNF-α,I L - 1 β, and IL-6) are produced in large quantities
by activated macrophages/monocytes that stimulate cellular
responses via increasing prostaglandins (PGs) and reactive
oxygen species (ROS). Additionally, lipid peroxidation (mal-
ondialdehyde, MDA) is produced by free radicals attacking
the cell membranes. Thus, inﬂammatory eﬀect can lead to
the accumulation of MDA [1].
Ficus pumila, a creeping vine like ﬁg plant, is native to
South China and Malaysia. Several studies have been perfor-
med on the composition of Ficus pumila,a n dan u m b e ro f
compounds have been identiﬁed such as apigenin, luteolin
[2],rutin,genistein,hesperidin,astragalin,isoquercitrin,and
chrysin [3]. Dried stems and leaves of Ficus pumila have been
folklorically used in the treatment of rheumatoid arthritis,
edema, tonic medicament, throat pain, and postpartum ab-
dominalpain[4].However,noresearchhasbeeninvestigated
on the analgesic and anti-inﬂammatory mechanisms of Ficus
pumila yet.
In this study, we investigated the analgesic and anti-in-
ﬂammatory activities of the methanol extract of Ficus pu-
mila (FPMeOH). The analgesic activity was evaluated by ace-
tic acid-induced writhing response and formalin test. Anti-
inﬂammatory activity was determined by using λ-carrage-
enan-induced mouse paw edema model and histopatholog-
ical analysis. In order to evaluate the mechanism of anti-in-
ﬂammatory eﬀect, we also analyzed TNF-α,I L - 1 β, COX-2,
MDA, and NO levels in the edema tissue, as well as antioxi-
dant enzyme activities of SOD (superoxidase dismutase),2 Evidence-Based Complementary and Alternative Medicine
GPx (glutathione peroxidase), and GRd (glutathione reduc-
tase) in the liver.
Manystudieshaveindicatedthatﬂavonoidsinherbspos-
sess anti-inﬂammatory activities via scavenging ROS and re-
ducing proinﬂammatory cytokines, such as rutin [5], lute-
olin [6], and apigenin [7]. These three ingredients have also
been isolated from Ficus pumila in previous studies [2, 3]. In
the phytochemical part of this study, not only did we re-
conﬁrmthepresenceofthesethreecompoundsinFPMeOH by
establishing its ﬁngerprint chromatogram, but also the con-
tents of these active ingredients were quantitatively deter-
mined.
2.MaterialsandMethods
2.1. Chemicals and Drugs. λ-carrageenan, indomethacin,
and Griess reagent were purchased from Uni-Onward (dis-
tributor of Sigma-Aldrich Chemical Co. in Taipei, Taiwan).
Formalin was purchased from Nihon Shiyaku Industry Ltd.
(Taipei, Taiwan). SOD, GPx, GRd, and MDA assay kits were
purchased from Eugene Chen Co. Ltd. (distributor of Ran-
dox Laboratory Ltd. in Taipei, Taiwan). IL-1β,I L - 6 ,C O X -
2, and TNF-α were obtained from Blossom Biotechnologies,
Inc. (agency of Assay Designs Inc. in Taipei, Taiwan). LC
grade acetonitrile was purchased from the branch company
of Merck in Taipei, Taiwan. All other reagents used were of
analytical grade.
2.2. Plant Material. Ficus pumila L. was collected from the
herbal garden of China Medical University, Taichung, Tai-
wan, as described in Flora of Taiwan [8]. A plant specimen
has been deposited in the School of Chinese Pharmaceutical
Sciences and Chinese Medicine Resources. Dried stems and
leaves (1.0kg) of Ficus pumila were sliced into small pieces,
soaked with 10 liters of methanol at room temperature for
three days. After passing through ﬁlter paper, the ﬁltrate
was concentrated under reduced pressure to dryness. The
above steps were repeated two additional times, and a total
of 123.1g of dry crude extract (yield ratio 12.31%) was
produced. The dried crude extract was dissolved in 0.5%
CMC (carboxymethyl cellulose) solution into three concen-
trations (100mg/mL, 50mg/mL, and 10mg/mL) prior to
pharmacological testing. Equal volume of 0.1mL (extract of
diﬀerent concentrations)/10g B.W. was given to each mouse
in all subsequent animal experiments.
2.3. Chromatographic Analysis of FPMeOH. The HPLC system
consisted of a Waters 2695 Alliance LC with 996 PDA. Chro-
matographic separation was performed on X-Bridge RP18
(25cm × 4.6mm I.D., 5μm) with an injection volume of
10μL. The mobile phase consisted of a mixture of 0.1%
formic acid (A) and acetonitrile (B) using a gradient elution.
The gradient program was set as follows: 0–15min, 20% B,
15–30min, 40% B, 30–45min, 60% B. The ﬂow rate was
set at 0.8mL/min and the detection wavelength was set to
255nm. The above conditions were used in both HPLC assay
and HPLC ﬁngerprint of FPMeOH.
The contents of rutin, apigenin, and luteolin of FPMeOH
were qualiﬁed and quantiﬁed in the HPLC assay. In qualita-
tiveanalyses,comparisonsweremadewiththeretentiontime
and maximum absorption of the standards. In quantitative
analyses, comparisons were made with peak areas under the
standard curves.
2.4. Experimental Animals. Male ICR mice aged between 5-
6 weeks and weighing between 20–25g were obtained from
BioLASCO Taiwan Co. Ltd. and were kept in the animal
center of China Medical University at a controlled temper-
ature of 22 ± 1◦C, relative humidity 55 ± 5%, and with
12h light/12h dark cycles for 1 week before the experiment.
Animals were provided with rodent diet and clean water
ad libitum. The experimental protocol was approved by the
Committee on Animal Research, China Medical University.
Animals were sacriﬁced by decapitation under ether anes-
thesia. All studies were conducted in accordance with the
National Institutes of Health (NIH) Guide for the Care and
Use of Laboratory Animals. All tests were conducted under
the guidelines of the International Association for the Study
of Pain [9].
2.5. Acute Toxicity Study. The acute toxicology test in mice
was carried out according to the method of Liao et al. [10].
Male ICR mice were randomly divided into three groups (10
mice per group). Three groups of mice were administered
orally with three concentrations of FPMeOH (2.5g, 5g, and
10g/kg), respectively. The experimental mice were kept
under regular observation for 14 days for any mortality or
behavioral changes.
2.6.AceticAcid-InducedWrithingResponse. Thewrithingtest
in mice was carried out according to the method of Koster
et al. [11]. Five randomly-selected groups of mice were orally
administered with solvent control (0.5% CMC), positive
control (indomethacin at 10mg/kg) or three diﬀerent doses
of FPMeOH (0.1, 0.5, and 1.0g/kg) 60min prior to the chemi-
cal stimulus. The number of muscular contractions was
counted 5min after the injection of 1% acetic acid (v/v,
0.1mL/10gbodyweight,i.p.).Thedatacollectedrepresented
thetotalnumberofwrithesobservedinadurationof10min-
utes (5–15min after the injection).
2.7. Formalin Test. The formalin test was conducted based
on the method of Tjølsen et al. [12]. Twenty microliters of
5% formalin in saline was injected subcutaneously into the
right hind paw of each mouse. The time (in seconds) spent
onlickingandbitingoftheinjectedpawwasrecordedinboth
the early phase (0–5min) and late phase (20–30min) after
theformalininjection.Solventcontrol(0.5%CMC),positive
control (indomethacin at 10mg/kg), or three diﬀerent doses
of FPMeOH (0.1, 0.5 and 1.0g/kg) was orally administered to
the animals 60min prior to the formalin injection.
2.8. λ-Carrageenan-Induced Mouse Paw Edema. The test was
conducted according to the method of Vinegar et al. [13].
The basal volume of right hind paw was determined before
the administration of any drug. Fifty microliters of 1% λ-
carrageenansuspendedinsalinewasinjectedintotheplantar
side of right hind paw, and the paw volume was measured at
the 1st, 2nd, 3rd, 4th, and 5thh after the injection using aEvidence-Based Complementary and Alternative Medicine 3
plethysmometer. The degree of swelling was evaluated by the
deltavolume(a-b),where“a”isthevolumeofrighthindpaw
after the chemical treatment and “b” is the volume before
the treatment. CMC (0.5%), indomethacin (10mg/kg), and
FPMeOH (0.1, 0.5 and 1.0g/kg) were administered orally
60min after the λ-carrageenan injection. In the secondary
experiment, another set of mice were orally administered
with 0.5% CMC, indomethacin, or FPMeOH 1hafterλ-car-
rageenan had been injected into their right hindpaws. The
right hindpaws of the animals were surgically removed un-
der anesthesia 2h following treatments. The paw tissue was
rinsed in ice-cold normal saline and immediately placed in
coldnormalsalinefourtimesitsvolumebeforehomogeniza-
tion at 4◦C. The homogenate was centrifuged at 12,000rpm
for5min.Thesupernatantwasobtainedandstoredat−20◦C
for the determinations of MDA, NO, TNF-α,I L - 1 β,a n d
COX-2. Similarly, the whole liver tissue was rinsed in ice-
cold normal saline and immediately placed in cold normal
saline of equal volume before homogenization at 4◦C. The
homogenate was then centrifuged at 12,000rpm for 5min.
The supernatant was obtained and stored at −20◦C for later
analyses of antioxidant enzyme (SOD, GPx, and GRd) activi-
ties.
2.9. Histological Analysis. The mice were orally administered
with 0.5% CMC, indomethacin, or FPMeOH 1hafterλ-car-
rageenan had been injected into their right hindpaws. The
right hindpaws of the animals were surgically removed un-
der anesthesia 2h after treatments. Tissue slices were ﬁxed in
10% formalin for 3 days, decalciﬁed overnight and embed-
ded in paraﬃn and sectioned into 4μm tissue sections. Tis-
sue sections were stained with hematoxylin and eosin (H&E
stain) before being examined under a BX60 microscope
(Olympus, Melville, NY) for pathological changes. Inﬂam-
matory reactions induced by λ-carrageenan, including paw
swelling and enlarged cavities, were examined. The severity
after FPMeOH (0.1, 0.5 and 1.0g/kg) and indomethacin
(10mg/kg) treatments was also examined. Images were ca-
ptured with a Macroﬁre 599831 camera. The results were
identiﬁed in the Animal Disease Diagnostic Center (ADDC),
National Chung Hsing University, Taichung, Taiwan.
2.10. MDA Assay. The production of MDA was induced by
λ-carrageenan injection, and evaluated by the thiobarbituric
acid reacting substance (TBARS) method [14]. Brieﬂy, MDA
reacted with TBARS at high temperature and formed a red-
complex TBARS. The absorbance of TBARS was recorded at
532nm.
2.11. NO Assay. NO was measured according to the method
of Moshage et al. [15]. NO3
− was converted into NO2
− by
nitrate reductase, NO2
− subsequently reacted with sulfanilic
acid to produce diazonium ion and coupled with N-(1-na-
phthyl) ethylenediamine to form the chromophoric aero-
derivative (purplish red) which could be recorded at 540nm.
2.12. TNF-α and IL-1β Assay. IL-1β was measured by an
enzyme-linked immunosorbent assay kit (Blossom Biotech-
nologies Inc.) [16]. The capture antibody of IL-1β was added
to each well of a 96-well plate overnight. Next day, a second
set of biotinylated antibody was incubated with sample tis-
sues or standard antigens in the plate before streptavidin was
added. The color of the reaction converted from purple to
yellow and was recorded at 450nm. TNF-α was detected
using the same method as IL-1β. Each sample was presented
as pg/mg in TNF-α and IL-1β concentrations.
2.13. COX-2 Assay. The content of COX-2 was determined
bymeasuringtheperoxidaseactivityofPGHS(prostaglandin
endoperoxideH2 synthase)[17].PeroxidaseactivityofPGHS
was determined by following the oxidation of N,N,N
 ,N
 -
tetramethyl-p-phenylenediamine (TMPD) at 37◦C using
arachidonate as the substrate. The increase in color was re-
corded at 590nm.
2.14. Measurement of Antioxidant Enzymes. SOD was mea-
sured according to the method of Vani et al. [18]. Xanthine
and xanthine oxidase (XOD) generated superoxide radicals
reacted with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyl-
tetrazolium chloride (I.N.T.) to form a red formazan dye,
and the color was recorded at 540nm. GPx was measured
according to the method of Ceballos-Picot et al. by detecting
the contents of GR and NADPH [19]. Oxidation of NADPH
into NADP+ is accompanied by a decrease in absorbance re-
corded at 340nm. GRd was measured according to the
method of Ahmad and Holdsworth [20] which detects the
decrease of glutathione (GSSG) in the presence of NADPH.
NADPH oxidized into NADP+ would result in a decrease in
absorbance recorded at 340nm.
2.15. Statistical Analysis. All data of each group were ex-
pressed as mean ± SD (n = 8). Statistical analyses were per-
formed with SPSS software and were carried out using one-
way ANOVA followed by Scheﬀe’s multiple range test.
3. Results
3.1. Chromatographic Analysis of FPMeOH. HPLC ﬁnger-
print proﬁle was established for FPMeOH (Figure 1). Three
ﬂavonoid components were identiﬁed as rutin, luteolin,
and apigenin with retention times of 13.8min, 35.2min,
and 40.4min, respectively. The maximum absorbance was
255nm, and the relative amounts for each gram of crude
extract were in the order of rutin (24.41mg), apigenin
(14.11mg), and luteolin (2.72mg).
3.2. Acute Toxicity Study. Acute toxicity of FPMeOH was
evaluated in mice at the doses of 2.5, 5 and 10g/kg. After
14 days of oral administration, FPMeOH did not cause any
behavioral changes, and no mortality was observed. There-
fore, the LD50 value of FPMeOH was concluded to be greater
than 10g/kg in mice, indicating it was practically not acutely
toxic.
3.3. Acetic Acid-Induced Writhing Response. Figure 2 shows
acetic acid-induced writhing responses in mice which serve
as an indication of analgesic activities of FPMeOH.I n t r a p e r i -
toneal injection of acetic acid produced 42.2 ± 5.6 writhes4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀect of FPMeOH and indomethacin on liver SOD, GPx, and GRd activities in mice injected with λ-carrageenan.
Groups SOD (U/g protein) GPx (U/mg protein) GRd (U/mg protein)
Normal 121.45 ±12.53 1.579 ±0.136 0.106 ±0.012
Car 67.69 ±16.43 0.949 ±0.144 0.063 ±0.014
Car + Indomethacin 99.72 ±10.36∗∗ 1.222 ±0.109 0.085 ±0.006∗∗
C a r+F P MeOH (0.1g/kg) 84.94 ±13.82∗ 1.287 ±0.133∗ 0.082 ±0.008∗∗
C a r+F P MeOH (0.5g/kg) 93.89 ±16.68∗ 1.332 ±0.207∗∗ 0.085 ±0.007∗∗
C a r+F P MeOH (1.0g/kg) 95.48 ±17.87∗ 1.339 ±0.224∗∗ 0.078 ±0.006∗
Each value represents the mean ± SD (n = 8). ∗P<0.05 and ∗∗P<0.01 as compared with the λ-carrageenan (Car) group (one-way ANOVA followed by
Scheﬀe’s multiple range test).
Table 2: Eﬀects of FPMeOH and indomethacin on the severity of
mouse paw edema.
Groups Grade (mean ± SD)
Car 3.6 ±0.55
Car + Indomethacin 2.0 ±0.71∗
C a r+F P MeOH (0.1g/kg) 3.6 ±0.55
C a r+F P MeOH (0.5g/kg) 3.0 ±0.00
C a r+F P MeOH (1.0g/kg) 2.2 ±0.45∗
Each value represents the mean ± SD (n = 5). ∗P<0.05 as compared
with the λ-carrageenan (Car) group (one-way ANOVA followed by Scheﬀe’s
multiple range test).
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Figure 1: HPLC ﬁngerprint of FPMeOH. The peaks represent 1. rutin
(13.8min), 2. luteolin (35.2min), and 3. apigenin (40.4min). The
contentsofrutin,apigenin,andluteolininFPMeOH were24.41mg/g,
14.11mg/g, and 2.72mg/g, respectively.
in the solvent control group. The writhing response was sig-
niﬁcantly reduced by pretreatments with FPMeOH (0.1, 0.5
and 1g/kg) and indomethacin (10mg/kg).
3.4. Formalin Test. In the early phase, FPMeOH- and indo-
methacin-treated groups did not show any signiﬁcant cha-
nges as compared to the solvent control group (Figure 3(a)).
In the second phase, subcutaneous injection of formalin in-
duced licking and biting responses in the solvent con-
trol group lasted for a period of 155.7 ± 10.5 seconds.
The time was signiﬁcantly decreased by pretreatment with
FPMeOH (0.1, 0.5 and 1g/kg) and indomethacin (10mg/kg)
(Figure 3(b)).
3.5. Eﬀect of FPMeOH on λ-Carrageenan-Induced Mouse
Paw Edema. Following the λ-carrageenan injection, the
volume of mouse paw increased as edema developed,
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Figure 2: Analgesic eﬀects of FPMeOH and indomethacin on acetic
acid-induced writhing response in mice. Each value represents
mean ±SD(n = 8).Thenumberofabdominalwritheswascounted
over the time period of 5–15min after acetic acid injection. ∗∗P<
0.01 and ∗∗∗P<0.001 as compared to the solvent control group
(one-way ANOVA followed by Scheﬀe’s multiple range test).
indicating inﬂammatory activities (Figure 4). However,
indomethacin (10mg/kg) and FPMeOH (0.1–1.0g/kg) signif-
icantly decreased paw edema at the 3rd, 4th, and 5thh after
the injection. FPMeOH at the concentrations of 0.5 and 1g/kg
had about equal amount of inhibition as indomethacin.
3.6. Histological Analysis. No inﬂammation, tissue destruc-
tion, and swelling phenomenon were observed in the paws of
normal mice (Figure 5(a)). On the other hand, the λ-carra-
geenan control group displayed enlarged cavities in the paw
tissue (Figure 5(b)). Edematous condition was obviously ab-
ated by treatment with 10mg/kg of indomethacin and
1.0g/kg of FPMeOH (Figures 5(c) and 5(f)). The severity
of mouse paw edema was also graded and summarized in
Table 2 (mean ± SD).
3.7. Eﬀect of FPMeOH on MDA Level. MDA level obviously
increased in the λ-carrageenan control group (1.120 ±
0.172μM / g ) ;h o w e v e r ,p r e t r e a t m e n t sw i t hF P MeOH (0.1, 0.5
and 1.0g/kg) and indomethacin (10mg/kg) signiﬁcantly
inhibited the increase of MDA levels (Figure 6).Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀects of FPMeOH and indomethacin on (a) early and (b)
late phases of formalin test in mice. Each value represents mean ±
SD (n = 8). The time spent on licking and biting the injected paws
was recorded in the time periods of 0–5min (early phase) and 20–
30min (late phase) as indicators of pain. ∗P<0.05 and ∗∗∗P<
0.001 as compared to the solvent control group (one-way ANOVA
followed by Scheﬀe’s multiple range test).
3.8. Eﬀect of FPMeOH on NO Level. Pretreatments with
FPMeOH (0.5 and 1.0g/kg) and indomethacin (10mg/kg) sig-
niﬁcantly inhibited the increase of NO levels in the edema
paws of mice, as compared to the λ-carrageenan control
group (10.08 ± 1.45μM), as shown in Figure 7.
3.9. Eﬀect of FPMeOH on TNF-α and IL-1β. TNF-α and
IL-1β levels in λ-carrageenan-induced edema paws were
increased remarkably. FPMeOH (0.5 and 1.0g/kg) and indo-
methacin (10mg/kg) signiﬁcantly reduced the levels of TNF-
α(Figure 8).Similarly,IL-1β levelsweresigniﬁcantlylowered
by FPMeOH (0.1, 0.5 and 1.0g/kg) and indomethacin, as
shown in Figure 9.
3.10. Eﬀect of FPMeOH on COX-2 Level. Figure 10 shows that
COX-2 level was greatly raised (37.04 ± 3.04 U/mg) in λ-
carrageenan induced edema paw. However, COX-2 levels
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Figure 4: Eﬀects of FPMeOH and indomethacin on λ-carrageenan-
induced mouse paw edema. The volumes of paw edema were
detected at the 1st, 2nd, 3rd, 4th, and 5thh after λ-carrageenan
injection. Each value represents mean ± SD (n = 8). ∗∗P<0.01
and ∗∗∗P<0.001 as compared to the λ-carrageenan control group
(one-way ANOVA followed by Scheﬀe’s multiple range test).
were decreased by treating with FPMeOH (0.5 and 1.0g/kg)
as well as indomethacin (10mg/kg).
3.11.EﬀectofFPMeOH ontheActivitiesofAntioxidantEnzymes.
SOD,GPx,andGRdactivitieswereincreasedbytreatingwith
FPMeOH (0.5 and 1.0g/kg) and indomethacin (10mg/kg), as
compared to the λ-carrageenan control group (Table 1).
4. Discussion
Ficus is a genus of about 800 species found in tropical and
subtropical regions. Several Ficus species have been studied
for their anti-inﬂammatory actions, for example, F. auranti-
acea [20], F. carica [21], F. glomerata [22], F. maxima [23],
and F. obtusifolia [24].
Traditional medicines have been popularly used in the
treatmentofvariousdiseasesinrecentyears.Manymedicinal
plants supply analgesic and anti-inﬂammatory activities to
treat acute, chronic, or recurring illnesses. Ficus pumila is a
Chineseherbalmedicine,itsdriedstemsandleaveshavebeen
commonly used in the treatmentof rheumatoid arthritis, ed-
ema,throatpain,andpostpartum abdominal pain[4].Based
on its therapeutic claims in traditional medicine, we inves-
tigated possible mechanisms of the analgesic and anti-in-
ﬂammatory eﬀects of FPMeOH.
Analgesic eﬀect of FPMeOH was evaluated by two ani-
mal models, including acetic acid-induced writhing re-
sponse and formalin test. The results of acetic acid induc-
ed writhing test showed that FPMeOH (0.1–1g/kg) and indo-
methacin (10mg/kg) provided antinociceptive eﬀects in
mice. Acetic acid indirectly triggers the release of nociceptive
endogenous mediators (such as bradykinin, serotonin, and6 Evidence-Based Complementary and Alternative Medicine
(a) (b) (c)
(d) (e) (f)
Figure 5: Histopathological examinations on λ-carrageenan-induced paw tissue swelling, edema and neutrophil inﬁltration: (a) normal, (b)
λ-carrageenan, (c) indomethacin, (d) FPMeOH (0.1g/kg), (e) FPMeOH (0.5g/kg), and (f) FPMeOH (1.0g/kg).
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∗∗∗P<0.001 as compared to the λ-carrageenan control group
(one-way ANOVA followed by Scheﬀe’s multiple range test).
prostaglandin) and proinﬂammatory cytokines (such as
TNF-α and IL-1β) to cause painful sensation [25]. This noci-
ceptive eﬀect can be prevented by analgesic agents with cen-
tral actions such as morphine as well as peripherally acting
drugs like NSAID.
I no r d e rt oe v a l u a t ew h e t h e rF P MeOH acted centrally or
peripherally in the suppression of pain, we also conducted
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Figure 7: Eﬀects of FPMeOH and indomethacin on NO concentra-
tions in the mouse edema paws. Each value represents mean ± SD
(n = 8). ∗∗P<0.01 and ∗∗∗P<0.001 as compared to the λ-
carrageenan control group (one-way ANOVA followed by Scheﬀe’s
multiple range test).
the formalin test. The formalin test involves a biphasic re-
sponse: the ﬁrst phase (neurogenic nociceptive response)
occurs in the ﬁrst 5min after the formalin injection, while
the second phase (inﬂammatory nociceptive response) oc-
curs between 15 to 30min after formalin injection. CentrallyEvidence-Based Complementary and Alternative Medicine 7
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Figure 8: Eﬀects of FPMeOH and indomethacin on TNF-α concen-
trations in mouse paw edema. Each value represents mean ± SD
(n = 8). ∗∗P<0.01 and ∗∗∗P<0.001 as compared to the λ-
carrageenan control group (one-way ANOVA followed by Scheﬀe’s
multiple range test).
acting drugs can inhibit both phases; however, peripherally
acting drugs, such as NSAID, only inhibit the second
phase [26] .T h et r e a t m e n t so fF P MeOH (0.1–1g/kg) and in-
domethacin(10mg/kg)wereabletodiminishthenociceptive
response in the second phase induced by formalin. The re-
sults indicated that the antinociceptive eﬀect of FPMeOH was
due to its peripheral anti-inﬂammatory eﬀect.
In the inﬂammatory model involving λ-carrageenan in-
jection, FPMeOH signiﬁcantly decreased the volume of paw
edema. The anti-inﬂammatory eﬀect was also evident when
we compared histopathological examinations of FPMeOH-
treatedgroupswiththatofλ-carrageenancontrolgroup.Paw
biopsy of the λ-carrageenan control group showed obvious
edematous condition and enlarged cavities in the connec-
tive tissues; on the other hand, the groups that received
10mg/kg of indomethacin or 1g/kg of FPMeOH had signif-
icant improvement in edematous condition and decreased
intercellular spaces in connective tissues as shown in Figure 5
and Table 2.
In our follow-up experiments that explored the mech-
anisms underlying the anti-inﬂammatory eﬀect of FPMeOH,
we suspected that suppression of inﬂammatory cytokines
may play an important role. λ-Carrageenan-induced paw ed-
ema has also been characterized as a biphasic event [13]:
histamine,bradykinin,and5-hydroxytryptamine(5-HT)are
released in the ﬁrst phase of edema (0-1h), while TNF-α,
IL-1β, COX-2, and PGs are produced more actively in
the second phase (1–6h). TNF-α and IL-1β have been re-
ported in several studies to be able to recruit leukocytes,
such as neutrophils [27, 28]. Additionally, COX-2 is an en-
zyme responsible for increasing prostaglandin levels in in-
ﬂammatoryreactions,whichcouldinturnworsenthedegree
of swelling [29]. In this study, FPMeOH (dose dependent)
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Figure 9: Eﬀects of FPMeOH and indomethacin on IL-1β concen-
trations in mouse paw edema. Each value represents mean ± SD
(n = 8). ∗∗P<0.01 and ∗∗∗P<0.001 as compared to the λ-
carrageenan control group (one-way ANOVA followed by Scheﬀe’s
multiple range test).
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Figure 10: Eﬀects of FPMeOH and indomethacin on COX-2 concen-
trations in mouse paw edema. Each value represented mean ± SD
(n = 8). ∗P<0.05 and ∗∗∗P<0.001 as compared to the λ-carrage-
enan control group (one-way ANOVA followed by Scheﬀe’s multi-
ple range test).
and indomethacin (10mg/kg) showed signiﬁcant anti-
inﬂammatory eﬀect in λ-carrageenan-induced mouse paw
edema from the 3rd to 5th h. Moreover, the levels of TNF-α,
IL-1β, and COX-2 were also decreased by treating with
FPMeOH andindomethacin (10mg/kg).Thus,aputativeanti-
inﬂammatory mechanism of FPMeOH could be associated
withtheinhibition ofinﬂammatorymediators,suchasTNF-
α,I L - 1 β, and COX-2.8 Evidence-Based Complementary and Alternative Medicine
Another possible mechanism behind the anti-inﬂam-
matory eﬀect of FPMeOH could be due to its antioxidative
activity. Increased production of TNF-α,I L - 1 β, and other
proinﬂammatory cytokines not only has the capacity to
recruit leukocytes, but would also trigger their release of
active substances such as ROS [30]. Nitric oxide, hydrogen
peroxide, hydroxyl radicals, and superoxide anions play
majorrolesintermsofproducingcellulardamage[31].MDA
is a reactive aldehyde caused by toxic stress in cells and form
covalent protein adducts which are referred to as advanced
lipid peroxidation end products (ALE). Inﬂammation would
result in the accumulation of MDA; on the other hand,
enhancing the level of GPx, GRd and SOD could reduce
MDA production [32]. In this study, SOD, GPx, and GRd
activities increased in the liver after treatment with FPMeOH.
Conversely, the level of MDA decreased signiﬁcantly. There-
fore, we believe that the suppression of MDA production
was likely associated to the increase in SOD, GPx, and GRd
activities.
The ﬁngerprint chromatogram of FPMeOH was estab-
lished, and its three ﬂavonoid contents (rutin, luteolin and
apigenin) were quantitatively determined. Three active com-
pounds of FPMeOH, rutin, luteolin, and apigenin, have been
previously demonstrated to possess anti-inﬂammatory and
antinociceptive activities which may be responsible, at least
in part, to the anti-inﬂammatory and antinociceptive eﬀects
of FPMeOH [5–7].
This study demonstrated that Ficus pumila exhibited
antinociceptive and anti-inﬂammatory activities. The anti-
inﬂammatory mechanisms of FPMeOH against λ-carrageen-
an-induced paw edema involved two possible pathways. The
ﬁrst pathway alleviated the levels of inﬂammatory factors,
such as IL-1β,T N F - α, and COX-2 in the edema paw induced
by λ-carrageenan. The other pathway was likely associated to
the decrease in MDA and NO levels in the edema paw via
increasing the activities of SOD, GPx, and GRd in the liver.
In conclusion, this study supported possible mechanisms of
FPMeOH used for mitigating inﬂammatory pain.
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